Abstract:Nonischemic dilated cardiomyopathy is a common form of heart muscle disease in which genetic factors play a critical etiological role. In this regard, both rare disease‐causing mutations and common disease‐susceptible variants, in the Bcl‐2–associated athanogene 3 ( BAG3 ) gene have been reported, highlighting the critical role of BAG3 in cardiomyocytes and in the development of dilated cardiomyopathy. The phenotypic effects of the BAG3 mutations help investigators understand the structure and function of the BAG3 gene. Indeed, we report herein that all of the known pathogenic/likely pathogenic variants affect at least 1 of 3 protein functional domains, ie, the WW domain, the second IPV (Ile‐Pro‐Val) domain, or the BAG domain, whereas none of the missense nontruncating pathogenic/likely pathogenic variants affect the proline‐rich repeat (PXXP) domain. A common variant, p.Cys151Arg, associated with reduced susceptibility to dilated cardiomyopathy demonstrated a significant difference in allele frequencies among diverse human populations, suggesting evolutionary selective pressure. As BAG3 ‐related therapies for heart failure move from the laboratory to the clinic, the ability to provide precision medicine will depend in large part on having a thorough understanding of the potential effects of both common and uncommon genetic variants on these target proteins. The current review article provides a roadmap that investigators can utilize to determine the potential interactions between a patient's genotype, their phenotype, and their response to therapeutic interventions with both gene delivery and small molecules. Nonstandard Abbreviations and Acronyms ACMG American College of Medical Genetics and Genomics B/LB benign/likely benign BAG3 Bcl‐2–associated athanogene 3 CAPZB capping actin protein of muscle Z‐line subunit beta DCM dilated cardiomyopathy eQTL expression quantitative trait locus gnomAD Genome Aggregation Database GTEx Genotype‐Tissue Expression Hsc70 heat shock cognate Hsp70 70 kilo‐dalton heat shock protein IPV Ile‐Pro‐Val LAMP‐2 lysosomal associated membrane protein 2 LTCC L‐type voltage‐gated calcium channel Cav1.2 LD linkage disequilibrium NF‐κB nuclear factor kappa B P/LP pathogenic/likely pathogenic PDZGEF2 PDZ domain containing guanine nucleotide exchange factor 2 PPCM peripartum cardiomyopathy PXXP proline‐rich repeat SH3 Src homology 3 sHsps small heat shock proteins SIFT Sorting Intolerant From Tolerant VUS variant of uncertain significance Cardiomyopathies are a heterogeneous group of diseases of cardiac muscle 1 that include dilated, hypertrophic, restrictive, constrictive and arrhythmogenic right ventricular cardiomyopathies. 2 Dilated cardiomyopathies (DCMs) have been historically separated into those that are secondary to ischemic heart disease (ischemic DCM) and those that are nonischemic, with ischemic DCM being somewhat more common. Genetic variants were first shown to be etiologic in the development of hypertrophic cardiomyopathy 3 , 4 and novel therapies have been developed, using gene therapy 5 or small molecules. 6 By contrast, the cause of DCM has remained more obscure. Recent studies have shown convincingly that both heritable and sporadic genetic variants play a -Abstract Truncated-

Titin As the Culprit Behind Dilated Cardiomyopathy: A Case Series of Three Cases and a Comprehensive Literature Review

Titin Cardiomyopathy Associated With Refractory Ventricular Tachycardia: A Case Report

Implication of TITIN Variations in Dilated Cardiomyopathy: Integrating Whole Exome Sequencing With Molecular Dynamics Simulation Study

Titin: The Missing Link in Cardiac Physiology

[A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report]

Identification of novel TTN gene variant in a patient exhibiting severe dilated cardiomyopathy co-occurring with acute fibrinoid organizing pneumonia

A Genetic Journey from Past to Future

Prevalence of Genetically Associated Dilated Cardiomyopathy: A Systematic Literature Review and Meta-Analysis

Genetic Determinant of Familial Dilated Cardiomyopathy and Genotype-Targeted Therapeutic Strategy

TTN novel splice variant in familial dilated cardiomyopathy and splice variants review: a case report

Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias

Emerging Concepts of Mechanisms Controlling Cardiac Tension: Focus on Familial Dilated Cardiomyopathy (DCM) and Sarcomere-Directed Therapies

Impaired Cardiomyocyte Maturation Leading to DCM: A Case Report and Literature Review.

Truncated titin is structurally integrated into the human dilated cardiomyopathic sarcomere

Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine

[Titin Gene Mutations in Chinese Patients with Dilated Cardiomyopathy].

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy

Atlas of the Clinical Genetics of Human Dilated Cardiomyopathy

A Comprehensive Outlook on Dilated Cardiomyopathy (DCM): State-Of-The-Art Developments with Special Emphasis on OMICS-Based Approaches

Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review

Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies